Penn Medicine Abramson Cancer Center


 

UPenn 2021 Updates on PTCL: Does the Addition of Romidepsin to CHOP Improve PFS in the Frontline Setting? How Responsive Is Duvelisib in R/R Disease?

126 views
March 7, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas